Disclosure
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH Inc. prior to accreditation of the activity.

Faculty
Naim Alkhouri, MD, FAASLD, D-ABOM, has a financial relationship: Consultant - 89bio, AbbVie, Akero, Boehringer Ingelheim, Echosens, Fibronostics, Gilead Sciences, HistoIndex, Intercept Pharmaceuticals, Ipsen, LiverRight, Madrigal Pharmaceuticals, NorthSea Therapeutics, Novo Nordisk, Perspectum, Pfizer, Regeneron, and Sonicy Incytes; Researcher - 89bio, Akero Therapeutics, Altimmune, Arbutus Biopharma, AstraZeneca, BioAge, Boehringer Ingelheim, Bristol Myers Squibb, Corcept Therapeutics, Galectin Therapeutics, Genentech, Gilead Sciences, GSK, Hepagene Therapeutics, Intercept Pharmaceuticals, Inventiva Pharma, Ionis Pharmaceuticals, Ipsen, Lilly, Madrigal Pharmaceuticals, Merck, NGM Biopharmaceuticals, NorthSea Therapeutics, Novo Nordisk, Perspectum, Pfizer, PharmaIN, Regeneron, Rivus, Viking Therapeutics; Speaker - AbbVie, AstraZeneca, Echosens, Gilead Sciences, Ipsen, Madrigal Pharmaceuticals, Novo Nordisk

Meena Bansal, MD, FAASLD, has a financial relationship: grant support—CDC/NIOSH, Histoindex, NIH, Petauri, Pfizer, Siemens, and The Kinetix Group; consultant—AstraZeneca, Boehringer-Ingelheim, Boston Pharma, Curve Biosciences, Echosens, Eli Lilly, Fibronostics, GSK, Madrigal Pharmaceuticals, mBIOTA, Merck, NOVO Nordisk, Pfizer, and The Kinetix Group.

Fernando Bril, MD, has a financial relationship: Advisor & Consultant - NovoNordisk, Boehringer-Ingelheim, Madrigal, Inventiva

Staff/Reviewers
Alexandra E. Marsillo, PhD, Catalyst Medical Education, LLC, Medical Director, has no financial relationships to disclose.
Louis Settembrino, CHCP, Catalyst Medical Education, LLC, President and CEO, has no financial relationships to disclose.
Dorothy Caputo, MA, BSN, RN, AKH Inc., President, Planner, has no financial relationships to disclose.
Rebecca Lakofsky, BSN, RN, AKH Inc., Planner/Reviewer, has no financial relationships to disclose.
Trish Brignoni, AKH Inc., Associate VP, has no financial relationships to disclose.
AKH Inc., Advancing Knowledge in Healthcare and Catalyst Medical Education, LLC, planners and reviewers have no financial relationships to disclose.

All of the relevant financial relationships listed for these individuals have been mitigated.

Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional and, therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants’ misunderstanding of the content. If you would like to opt out from future communications from AKH Inc., please send an email to [email protected] with your information with “Opt Out” in the subject line.

Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the U.S. Food and Drug Administration (FDA). Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.